Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Steven Cohen, Ray Dalio, David Einhorn, Novocure Ltd (NVCR), USANA Health Sciences, Inc. (USNA), and More

Insider Selling: Novocure Ltd (NVCR) COO Sells 57,390 Shares of Stock (LedgerGazette.com)
Novocure Ltd (NASDAQ:NVCR) COO Michael J. Ambrogi sold 57,390 shares of Novocure stock in a transaction that occurred on Monday, July 2nd. The shares were sold at an average price of $31.48, for a total transaction of $1,806,637.20. Following the completion of the transaction, the chief operating officer now directly owns 174,383 shares in the company, valued at approximately $5,489,576.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Insider Selling: USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $3,547,083.28 in Stock (WeekHerald.com)
USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 30,796 shares of the business’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $115.18, for a total value of $3,547,083.28. Following the completion of the transaction, the insider now owns 10,518,064 shares in the company, valued at approximately $1,211,470,611.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

https://macondaily.com/2018/07/05/insider-buying-protokinetix-inc-pktx-ceo-acquires-840760-shares-of-stock.html (MaconDaily.com)
ProtoKinetix, Inc. (OTCMKTS:PKTX) CEO Clarence Edward Smith bought 840,760 shares of the business’s stock in a transaction that occurred on Friday, June 29th. The stock was purchased at an average cost of $0.05 per share, with a total value of $42,038.00. The acquisition was disclosed in a legal filing with the SEC.

Insider Selling: Paratek Pharmaceuticals Inc (PRTK) COO Sells 12,000 Shares of Stock (WeekHerald.com)
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) COO Evan Loh sold 12,000 shares of the firm’s stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $9.97, for a total value of $119,640.00. Following the transaction, the chief operating officer now owns 202,786 shares of the company’s stock, valued at $2,021,776.42. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Insider Selling: 1-800-Flowers.Com Inc (FLWS) CEO Sells $189,750.00 in Stock (MaconDaily.com)
1-800-Flowers.Com Inc (NASDAQ:FLWS) CEO Christopher G. Mccann sold 15,000 shares of 1-800-Flowers.Com stock in a transaction on Monday, July 2nd. The shares were sold at an average price of $12.65, for a total value of $189,750.00. Following the transaction, the chief executive officer now owns 965,626 shares in the company, valued at $12,215,168.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.